Traws Pharma, Inc. Investment Income, Interest
Traws Pharma, Inc. (TRAW) reported Investment Income, Interest of $455.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-04-15
- Traws Pharma, Inc. investment income, interest for fiscal 2025 was $455.00K, a 10.78% decline from fiscal 2024.
- Traws Pharma, Inc. investment income, interest for fiscal 2024 was $510.00K, a 63.34% decline from fiscal 2023.
- Traws Pharma, Inc. investment income, interest for fiscal 2023 was $1.39M, a 113.67% increase from fiscal 2022.
- Traws Pharma, Inc. investment income, interest for fiscal 2022 was $651.00K.
| Period end | Investment Income, Interest 12 month |
|---|---|
| 2025-12-31 | $455.00K 10-K · filed 2026-04-15 |
| 2024-12-31 | $510.00K 10-K · filed 2026-04-15 |
| 2023-12-31 | $1.39M 10-K · filed 2025-03-31 |
| 2022-12-31 | $651.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |